IMNM logo

Immunome (IMNM)

Profile

Full Name

Immunome, Inc.

Ticker Symbol

IMNM

Exchange

NASDAQ

Country

United States

IPO

October 2, 2020

Indexes

Not included

Employees

118

Key Details

Price

$5.93

Market Cap

$515.62M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$9.04M(-35.50% YoY)

Annual EPS

-$5.00(+7.06% YoY)

PE Ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 20, 25 Wedbush
Outperform
Mar 20, 25 Stephens & Co.
Overweight
Mar 20, 25 Guggenheim
Buy
Mar 11, 25 LifeSci Capital
Outperform
Nov 14, 24 Piper Sandler
Overweight
Nov 8, 24 Stephens & Co.
Overweight
Oct 25, 24 Wedbush
Outperform
Aug 13, 24 Wedbush
Outperform
Aug 13, 24 Piper Sandler
Overweight
May 31, 24 Piper Sandler
Overweight

Institutional Ownership

  • What is the ticker symbol for Immunome?
  • Does Immunome pay dividends?
  • What sector is Immunome in?
  • What industry is Immunome in?
  • What country is Immunome based in?
  • When did Immunome go public?
  • Is Immunome in the S&P 500?
  • Is Immunome in the NASDAQ 100?
  • Is Immunome in the Dow Jones?
  • When was Immunome's last earnings report?
  • When does Immunome report earnings?
  • Should I buy Immunome stock now?

What is the ticker symbol for Immunome?

The ticker symbol for Immunome is NASDAQ:IMNM

Does Immunome pay dividends?

No, Immunome does not pay dividends

What sector is Immunome in?

Immunome is in the Healthcare sector

What industry is Immunome in?

Immunome is in the Biotechnology industry

What country is Immunome based in?

Immunome is headquartered in United States

When did Immunome go public?

Immunome's initial public offering (IPO) was on October 2, 2020

Is Immunome in the S&P 500?

No, Immunome is not included in the S&P 500 index

Is Immunome in the NASDAQ 100?

No, Immunome is not included in the NASDAQ 100 index

Is Immunome in the Dow Jones?

No, Immunome is not included in the Dow Jones index

When was Immunome's last earnings report?

Immunome's most recent earnings report was on Mar 19, 2025

When does Immunome report earnings?

The next expected earnings date for Immunome is May 14, 2025

Should I buy Immunome stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page